3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
4
Gastrointestinal
2
Thoracic
1
Genitourinary
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
1865
Lung Neoplasms
1300
Small Cell Lung Carcinoma
327
Colorectal Neoplasms
275
Breast Neoplasms
244
Melanoma
222
Neoplasms
214
Ovarian Neoplasms
192
Neoplasm Metastasis
184
Pancreatic Neoplasms
155
Squamous Cell Carcinoma of Head and Neck
150
Stomach Neoplasms
141
Head and Neck Neoplasms
122
Carcinoma, Renal Cell
120
Triple Negative Breast Neoplasms
109
Prostatic Neoplasms
107
Esophageal Neoplasms
107
Endometrial Neoplasms
98
Uterine Cervical Neoplasms
96
Urinary Bladder Neoplasms
88
Colonic Neoplasms
87
Mesothelioma
86
Mesothelioma, Malignant
80
Carcinoma, Hepatocellular
75
Brain Neoplasms
71
Sarcoma
63
Disease
62
Adenocarcinoma of Lung
60
Carcinoma, Transitional Cell
54
Gastrointestinal Neoplasms
50
Interventions
brigimadlin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Tertiary Lymphoid Structures
×
Thoracic
×
1 year
×
Clear all
NCT06084689
2025-09-02
EMPIRE
Institut Bergonié
Phase 2
Withdrawn